Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +7 vs. Q1 2022
- Shares held
- 25.8M
- −140.2K (−0.5%) vs. Q1 2022
- Total value
- $403.0M
- −$72.1M (−15.2%) vs. Q1 2022
- New holders
- 9
- 7 more added
- Sold out
- 2
- 25 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $129.2M | 3.44% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $58.7M | 5.23% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,638,297 | $41.2M | 6.89% | −465,582−15.0% | Reduced |
| Baker Bros. Advisors LP | 2,070,010 | $32.4M | 0.18% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,730,691 | $27.1M | 2.10% | −100,000−5.5% | Reduced |
| Citadel Advisors LLC | 1,592,009 | $24.9M | 0.03% | −1,367−0.1% | Reduced |
| TCG Crossover Management, LLC | 889,572 | $13.9M | 5.91% | 00.0% | Unchanged |
| BlackRock Inc. | 705,368 | $11.0M | 0.00% | −41,566−5.6% | Reduced |
| FMR LLC | 634,766 | $9.92M | 0.00% | −84,708−11.8% | Reduced |
| OUP Management Co., LLC | 603,762 | $9.44M | 12.99% | 00.0% | Unchanged |
| VR Adviser, LLC | 590,408 | $9.23M | 1.82% | +439,371+290.9% | Added |
| OrbiMed Advisors LLC | 478,579 | $7.48M | 0.15% | −31,370−6.2% | Reduced |
| Vanguard Group Inc | 442,401 | $6.92M | 0.00% | −37,709−7.9% | Reduced |
| Sectoral Asset Management Inc | 196,038 | $3.06M | 0.62% | −22,875−10.4% | Reduced |
| Lynx1 Capital Management LP | 191,565 | $2.99M | 2.55% | +124,588+186.0% | Added |
| State Street Corp | 178,554 | $2.79M | 0.00% | +10,517+6.3% | Added |
| Fred Alger Management, LLC | 172,706 | $2.70M | 0.01% | +5,699+3.4% | Added |
| Geode Capital Management, LLC | 166,162 | $2.60M | 0.00% | −29,025−14.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 100,000 | $1.56M | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 76,140 | $1.19M | 0.00% | −28,310−27.1% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 56,431 | $882.0K | 0.01% | +42,323+300.0% | Added |
| Nuveen Asset Management, LLC | 38,788 | $606.0K | 0.00% | +24,470+170.9% | Added |
| Parkwood LLC | 32,414 | $507.0K | 0.10% | +32,414 | New |
| Bank of New York Mellon Corp | 25,067 | $392.0K | 0.00% | −5,420−17.8% | Reduced |
| Millennium Management LLC | 24,066 | $376.0K | 0.00% | +24,066 | New |
| Charles Schwab Investment Management Inc | 23,836 | $373.0K | 0.00% | −9,017−27.4% | Reduced |
| Ergoteles LLC | 18,000 | $281.0K | 0.01% | +18,000 | New |
| Chicago Partners Investment Group LLC | 10,163 | $226.0K | 0.02% | +10,163 | New |
| Rhumbline Advisers | 13,193 | $206.0K | 0.00% | +13,193 | New |
| Jane Street Group, LLC | 11,717 | $183.0K | 0.00% | +11,717 | New |
| Morgan Stanley | 7,929 | $124.0K | 0.00% | +370+4.9% | Added |
| JPMorgan Chase & Co | 5,876 | $92.0K | 0.00% | −3,131−34.8% | Reduced |
| New York State Common Retirement Fund | 5,186 | $81.0K | 0.00% | −7,405−58.8% | Reduced |
| Deutsche Bank AG | 4,342 | $68.0K | 0.00% | −1,104−20.3% | Reduced |
| American International Group, Inc. | 4,297 | $67.0K | 0.00% | −2,197−33.8% | Reduced |
| Barclays PLC | 4,024 | $63.0K | 0.00% | −1,763−30.5% | Reduced |
| California State Teachers Retirement System | 3,927 | $61.0K | 0.00% | −1,675−29.9% | Reduced |
| STRS Ohio | 2,300 | $35.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,031 | $32.0K | 0.00% | −2,072−50.5% | Reduced |
| Russell Investments Group, Ltd. | 2,056 | $32.0K | 0.00% | +2,056 | New |
| Amalgamated Bank | 1,199 | $19.0K | 0.00% | −263−18.0% | Reduced |
| Citigroup Inc | 1,078 | $17.0K | 0.00% | −342−24.1% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 515 | $8.00K | 0.00% | −903−63.7% | Reduced |
| Legal & General Group Plc | 414 | $6.00K | 0.00% | −927−69.1% | Reduced |
| Wells Fargo & Company | 118 | $2.00K | 0.00% | −1,379−92.1% | Reduced |
| Royal Bank of Canada | 52 | $1.00K | 0.00% | −752−93.5% | Reduced |
| Daiwa Securities Group Inc. | 73 | $1.00K | 0.00% | 00.0% | Unchanged |
| FinTrust Capital Advisors, LLC | 82 | $1.00K | 0.00% | +82 | New |
| Ellevest, Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 11 | $0 | 0.00% | +11 | New |
| Penn Mutual Asset Management, LLC | 0 | $0 | 0.00% | −17,458−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −953−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |